Protective and pathological functions of CD8+ T cells in Leishmania braziliensis infection

Infection and Immunity

Volumn 83, Issue 3, 2015, Pages 898-906

  Cardoso, Thiago Marconi ^a,b   Machado, Álvaro ^a   Costa, Diego Luiz ^c   Carvalho, Lucas P ^a,b   Queiroz, Adriano ^a,b   Machado, Paulo ^a,b   Scott, Phillip ^d   Carvalho, Edgar M ^a,b   Bacellar, Olívia ^a,b  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b Instituto Nacional de Ciência e Tecnologia de Doenças Tropicais INCT DT CNPq MCT   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GRANZYME B; TUMOR NECROSIS FACTOR ALPHA; BENZYLOXYCARBONYLVALYL-ALANYL-ASPARTYL FLUOROMETHYL KETONE; ENZYME INHIBITOR; GRANZYME; PARASITE ANTIGEN; PEPTIDE CHLOROMETHYL KETONE; TUMOR NECROSIS FACTOR;

APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; HUMAN; HUMAN CELL; INFECTION CONTROL; LEISHMANIA BRAZILIENSIS; LYMPHOCYTE FUNCTION; MACROPHAGE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SKIN LEISHMANIASIS; TARGET CELL; ANTAGONISTS AND INHIBITORS; ASYMPTOMATIC DISEASE; BIOSYNTHESIS; CHRONIC DISEASE; COCULTURE; CYTOTOXIC T LYMPHOCYTE; DRUG EFFECTS; IMMUNOLOGY; LYMPHOCYTE COUNT; METABOLISM; PARASITOLOGY; PATHOGENICITY; PATHOLOGY; PRIMARY CELL CULTURE; SECRETION (PROCESS);

AMINO ACID CHLOROMETHYL KETONES; ANTIGENS, PROTOZOAN; APOPTOSIS; ASYMPTOMATIC DISEASES; CD4-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; COCULTURE TECHNIQUES; CYTOTOXICITY, IMMUNOLOGIC; ENZYME INHIBITORS; GRANZYMES; HUMANS; INTERFERON-GAMMA; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS, CUTANEOUS; LYMPHOCYTE COUNT; MONOCYTES; PRIMARY CELL CULTURE; T-LYMPHOCYTES, CYTOTOXIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84923039374     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.02404-14     Document Type: Article

References (39)

1. Alvar J, Velez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, den Boer M, WHO Leishmaniasis Control Team. 2012. Leishmaniasis worldwide and global estimates of its incidence. PLoS One 7:e35671. http://dx.doi.org/10.1371/journal.pone.0035671.
2. Malherbe L, Filippi C, Julia V, Foucras G, Moro M, Appel H, Wucherpfennig K, Guery JC, Glaichenhaus N. 2000. Selective activation and expansion of high-affinity CD4+ T cells in resistant mice upon infection with Leishmania major. Immunity 13:771-782. http://dx.doi.org/10.1016/S1074-7613(00)00075-3.
3. Heinzel FP, Sadick MD, Holaday BJ, Coffman RL, Locksley RM. 1989. Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J Exp Med 169:59-72.
4. Belkaid Y, Von Stebut E, Mendez S, Lira R, Caler E, Bertholet S, Udey MC, Sacks D. 2002. CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major. J Immunol 168:3992-4000. http://dx.doi.org/10.4049/jimmunol.168.8.3992.
5. Uzonna JE, Joyce KL, Scott P. 2004. Low dose Leishmania major promotes a transient T helper cell type 2 response that is down-regulated by interferon gamma-producing CD8+ T cells. J Exp Med 199:1559-1566. http://dx.doi.org/10.1084/jem.20040172.
6. Bacellar O, Lessa H, Schriefer A, Machado P, Ribeiro de Jesus A, Dutra WO, Gollob KJ, Carvalho EM. 2002. Up-regulation of Th1-type responses in mucosal leishmaniasis patients. Infect Immun 70:6734-6740. http://dx.doi.org/10.1128/IAI.70.12.6734-6740.2002.
7. Mendes DS, Dantas ML, Gomes JM, dos Santos WL, Silva AQ, Guimaraes LH, Machado PR, de Carvalho EM, Arruda S. 2013. Inflammation in disseminated lesions: an analysis of CD4+, CD20+, CD68+, CD31+ and vW+ cells in non-ulcerated lesions of disseminated leishmaniasis. Mem Inst Oswaldo Cruz 108:18-22. http://dx.doi.org/10.1590/S0074-02762013000100003.
8. Antonelli LR, Dutra WO, Almeida RP, Bacellar O, Carvalho EM, Gollob KJ. 2005. Activated inflammatory T cells correlate with lesion size in human cutaneous leishmaniasis. Immunol Lett 101:226-230. http://dx.doi.org/10.1016/j.imlet.2005.06.004.
9. Faria DR, Gollob KJ, Barbosa J, Jr, Schriefer A, Machado PR, Lessa H, Carvalho LP, Romano-Silva MA, de Jesus AR, Carvalho EM, Dutra WO. 2005. Decreased in situ expression of interleukin-10 receptor is correlated with the exacerbated inflammatory and cytotoxic responses observed in mucosal leishmaniasis. Infect Immun 73:7853-7859. http://dx.doi.org/10.1128/IAI.73.12.7853-7859.2005.
10. Carvalho LP, Passos S, Bacellar O, Lessa M, Almeida RP, Magalhaes A, Dutra WO, Gollob KJ, Machado P, de Jesus AR. 2007. Differential immune regulation of activated T cells between cutaneous and mucosal leishmaniasis as a model for pathogenesis. Parasite Immunol 29:251-258. http://dx.doi.org/10.1111/j.1365-3024.2007.00940.x.
11. Da-Cruz AM, Conceicao-Silva F, Bertho AL, Coutinho SG. 1994. Leishmania-reactive CD4+ and CD8+ T cells associated with cure of human cutaneous leishmaniasis. Infect Immun 62:2614-2618.
12. Da-Cruz AM, Bertho AL, Oliveira-Neto MP, Coutinho SG. 2005. Flow cytometric analysis of cellular infiltrate from American tegumentary leishmaniasis lesions. Br J Dermatol 153:537-543. http://dx.doi.org/10.1111/j.1365-2133.2005.06647.x.
13. Barral-Netto M, Barral A, Brodskyn C, Carvalho EM, Reed SG. 1995. Cytotoxicity in human mucosal and cutaneous leishmaniasis. Parasite Immunol 17:21-28. http://dx.doi.org/10.1111/j.1365-3024.1995.tb00962.x.
14. Brodskyn CI, Barral A, Boaventura V, Carvalho E, Barral-Netto M. 1997. Parasite-driven in vitro human lymphocyte cytotoxicity against autologous infected macrophages from mucosal leishmaniasis. J Immunol 159:4467-4473.
15. Faria DR, Souza PE, Duraes FV, Carvalho EM, Gollob KJ, Machado PR, Dutra WO. 2009. Recruitment of CD8(+) T cells expressing granzyme A is associated with lesion progression in human cutaneous leishmaniasis. Parasite Immunol 31:432-439. http://dx.doi.org/10.1111/j.1365-3024.2009.01125.x.
16. Santos Cda S, Boaventura V, Ribeiro Cardoso C, Tavares N, Lordelo MJ, Noronha A, Costa J, Borges VM, de Oliveira CI, Van Weyenbergh J, Barral A, Barral-Netto M, Brodskyn CI. 2013. CD8(+) granzyme B(+)-mediated tissue injury vs. CD4(+)IFNgamma(+)-mediated parasite killing in human cutaneous leishmaniasis. J Invest Dermatol 133: 1533-1540. http://dx.doi.org/10.1038/jid.2013.4.
17. Jirmanus L, Glesby MJ, Guimaraes LH, Lago E, Rosa ME, Machado PR, Carvalho EM. 2012. Epidemiological and clinical changes in American tegumentary leishmaniasis in an area of Leishmania (Viannia) braziliensis transmission over a 20-year period. Am J Trop Med Hyg 86:426-433. http://dx.doi.org/10.4269/ajtmh.2012.11-0378.
18. Follador I, Araujo C, Bacellar O, Araujo CB, Carvalho LP, Almeida RP, Carvalho EM. 2002. Epidemiologic and immunologic findings for the subclinical form of Leishmania braziliensis infection. Clin Infect Dis 34: E54-E58. http://dx.doi.org/10.1086/340261.
19. Schnorr D, Muniz AC, Passos S, Guimaraes LH, Lago EL, Bacellar O, Glesby MJ, Carvalho EM. 2012. IFN-gamma production to leishmania antigen supplements the leishmania skin test in identifying exposure to L. braziliensis infection. PLoS Negl Trop Dis 6:e1947. http://dx.doi.org/10.1371/journal.pntd.0001947.
20. Novoa R, Bacellar O, Nascimento M, Cardoso TM, Ramasawmy R, Oliveira WN, Schriefer A, Carvalho EM. 2011. IL-17 and regulatory cytokines (IL-10 and IL-27) in L. braziliensis infection. Parasite Immunol 33:132-136. http://dx.doi.org/10.1111/j.1365-3024.2010.01256.x.
21. Reed SG, Badaro R, Masur H, Carvalho EM, Lorenco R, Lisboa A, Teixeira R, Johnson WD, Jr, Jones TC. 1986. Selection of a skin test antigen for American visceral leishmaniasis. Am J Trop Med Hyg 35:79-85.
22. Khamesipour A, Nateghi Rostami M, Tasbihi M, Miramin Mohammadi A, Shahrestani T, Sarrafnejad A, Sohrabi Y, Eskandari SE, Keshavarz Valian H. 2012. Phenotyping of circulating CD8(+) T cell subsets in human cutaneous leishmaniasis. Microbes Infect 14:702-711. http://dx.doi.org/10.1016/j.micinf.2012.02.006.
23. Derby E, Reddy V, Kopp W, Nelson E, Baseler M, Sayers T, Malyguine A. 2001. Three-color flow cytometric assay for the study of the mechanisms of cell-mediated cytotoxicity. Immunol Lett 78:35-39. http://dx.doi.org/10.1016/S0165-2478(01)00226-7.
24. Ruiz JH, Becker I. 2007. CD8 cytotoxic T cells in cutaneous leishmaniasis. Parasite Immunol 29:671-678. http://dx.doi.org/10.1111/j.1365-3024.2007.00991.x.
25. Hernandez-Ruiz J, Becker I. 2006. CD8+ cytotoxic lymphocytes in cutaneous leishmaniasis. Salud Publica Mex 48:430-439. http://dx.doi.org/10.1590/S0036-36342006000500009.
26. Hernandez-Ruiz J, Salaiza-Suazo N, Carrada G, Escoto S, Ruiz-Remigio A, Rosenstein Y, Zentella A, Becker I. 2010. CD8 cells of patients with diffuse cutaneous leishmaniasis display functional exhaustion: the latter is reversed, in vitro, by TLR2 agonists. PLoS Negl Trop Dis 4:e871. http://dx.doi.org/10.1371/journal.pntd.0000871.
27. Chavez-Galan L, Arenas-Del Angel MC, Zenteno E, Chavez R, Lascurain R. 2009. Cell death mechanisms induced by cytotoxic lymphocytes. Cell Mol Immunol 6:15-25. http://dx.doi.org/10.1038/cmi.2009.3.
28. Carvalho LP, Passos S, Schriefer A, Carvalho EM. 2012. Protective and pathologic immune responses in human tegumentary leishmaniasis. Front Immunol 3:301. http://dx.doi.org/10.3389/fimmu.2012.00301.
29. Gollob KJ, Antonelli LR, Faria DR, Keesen TS, Dutra WO. 2008. Immunoregulatory mechanisms and CD4+ CD8+ (double negative) T cell subpopulations in human cutaneous leishmaniasis: a balancing act between protection and pathology. Int Immunopharmacol 8:1338-1343. http://dx.doi.org/10.1016/j.intimp.2008.03.016.
30. Da-Cruz AM, de Oliveira MP, De Luca PM, Mendonca SC, Coutinho SG. 1996. Tumor necrosis factor-alpha in human American tegumentary leishmaniasis. Mem Inst Oswaldo Cruz 91:225-229. http://dx.doi.org/10.1590/S0074-02761996000200019.
31. Lessa MM, Lessa HA, Castro TW, Oliveira A, Scherifer A, Machado P, Carvalho EM. 2007. Mucosal leishmaniasis: epidemiological and clinical aspects. Braz J Otorhinolaryngol 73:843-847. http://dx.doi.org/10.1590/S0034-72992007000600016.
32. Lessa HA, Machado P, Lima F, Cruz AA, Bacellar O, Guerreiro J, Carvalho EM. 2001. Successful treatment of refractory mucosal leishmaniasis with pentoxifylline plus antimony. Am J Trop Med Hyg 65:87-89.
33. Bottrel RL, Dutra WO, Martins FA, Gontijo B, Carvalho E, Barral-Netto M, Barral A, Almeida RP, Mayrink W, Locksley R, Gollob KJ. 2001. Flow cytometric determination of cellular sources and frequencies of key cytokineproducing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis. Infect Immun 69: 3232-3239. http://dx.doi.org/10.1128/IAI.69.5.3232-3239.2001.
34. Nateghi Rostami M, Keshavarz H, Edalat R, Sarrafnejad A, Shahrestani T, Mahboudi F, Khamesipour A. 2010. CD8+ T cells as a source of IFN-gamma production in human cutaneous leishmaniasis. PLoS Negl Trop Dis 4:e845. http://dx.doi.org/10.1371/journal.pntd.0000845.
35. Jayakumar A, Castilho TM, Park E, Goldsmith-Pestana K, Blackwell JM, McMahon-Pratt D. 2011. TLR1/2 activation during heterologous prime-boost vaccination (DNA-MVA) enhances CD8+ T cell responses providing protection against Leishmania (Viannia). PLoS Negl Trop Dis 5:e1204. http://dx.doi.org/10.1371/journal.pntd.0001204.
36. Bogdan C. 2008. Mechanisms and consequences of persistence of intracellular pathogens: leishmaniasis as an example. Cell Microbiol 10:1221-1234. http://dx.doi.org/10.1111/j.1462-5822.2008.01146.x.
37. Giudice A, Vendrame C, Bezerra C, Carvalho LP, Delavechia T, Carvalho EM, Bacellar O. 2012. Macrophages participate in host protection and the disease pathology associated with Leishmania braziliensis infection. BMC Infect Dis 12:75. http://dx.doi.org/10.1186/1471-2334-12-75.
38. Bosque F, Saravia NG, Valderrama L, Milon G. 2000. Distinct innate and acquired immune responses to Leishmania in putative susceptible and resistant human populations endemically exposed to L. (Viannia) panamensis infection. Scand J Immunol 51:533-541. http://dx.doi.org/10.1046/j.1365-3083.2000.00724.x.
39. Silverio JC, Pereira IR, Cipitelli Mda C, Vinagre NF, Rodrigues MM, Gazzinelli RT, Lannes-Vieira J. 2012. CD8+ T-cells expressing interferon gamma or perforin play antagonistic roles in heart injury in experimental Trypanosoma cruzi-elicited cardiomyopathy. PLoS Pathog 8:e1002645. http://dx.doi.org/10.1371/journal.ppat.1002645.